NOS2 and neoplasm: Elevated NOS2 expression has been identified in precancerous lesions [19] and numerous studies suggest a potential use of NOS2 as a predictive cancer biomarker with high NOS2 tumor expression being associated with poor patient survival in several types of cancer including melanoma, prostate, and breast [22]–[27].